Prevalence of diabetes and diabetic nephropathy in a large U.S. commercially insured pediatric population, 2002-2013

Diabetes Care

Volumn 39, Issue 2, 2016, Pages 278-284

  Li, Lin ^a   Jick, Susan ^a   Breitenstein, Stefanie ^b   Michel, Alexander ^b  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGE; ARTICLE; CHILD; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; FEMALE; GENDER; HEALTH INSURANCE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCHOOL CHILD; SCHOOL CHILD; SEX DIFFERENCE; UNITED STATES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FACTUAL DATABASE; PREVALENCE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; PREVALENCE; UNITED STATES;

EID: 84962106927     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-1710     Document Type: Article

References (35)

1. Craig ME, Jefferies C, Dabelea D, Balde N, Seth A, Donaghue KC; International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2014. Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes 2014;15(Suppl. 20):4-17
2. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr 2005;146:693-700
3. Thanabalasingham G, Owen KR. Type 2 diabetes in the young: why we should worry. Practical Diabetes 2014;31:225-227
4. Dart AB, Martens PJ, Rigatto C, Brownell MD, Dean HJ, Sellers EA. Earlier onset of complications in youth with type 2 diabetes. Diabetes Care 2014;37:436-443
5. Luk AO, Lau ES, So WY, et al. Prospective study on the incidences of cardiovascular-renal complications in Chinese patients with young-onset type 1 and type 2 diabetes. Diabetes Care 2014;37:149-157
6. Song SH. Complication characteristics between young-onset type 2 versus type 1 diabetes in a UK population. BMJ Open Diabetes Res Care 2015;3:e000044
7. Hamman RF, Bell RA, Dabelea D, et al.; SEARCH for Diabetes in Youth Study Group. The SEARCH for Diabetes in Youth study: rationale, findings, and future directions. Diabetes Care 2014;37:3336-3344
8. Dabelea D, Mayer-Davis EJ, Saydah S, et al.; SEARCH for Diabetes in Youth Study. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 2014; 311:1778-1786
9. MarketScan bibliography [Internet]. Available from http://interest.truvenhealth.com/content/ DownloadLibrary-LifeSciences. Accessed 23 December 2014
10. Hansen L, Chang S. White paper. Health research data for the real world: the MarketScan Databases. Truven Health Analytics, 2012
11. Grosse SD, Boulet SL, Grant AM, Hulihan MM, Faughnan ME. The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia. Genet Med 2014;16:33-39
12. Pickens G, Moldwin E, Marder WD. Healthcare spending index for employer-sponsored insurance: methodology and baseline results [Internet]. Available from http://truvenhealth .com/Portals/0/Assets/HealthInsights/TRU-15667- 0415-HSI-ESI-WP.pdf. Accessed 15 September 2015
13. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic ne-phropathy: diagnosis, prevention, and treatment. Diabetes Care 2005;28:164-176
14. Rothman KJ, Boice JD Jr. Epidemiologic Analysis with a Programmable Calculator. Washington, DC, U.S. Govt. Printing Office, 1979 (NIH publ. no. 79-1649)
15. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19: 335-351
16. Vehik K, Hamman RF, Lezotte D, et al. Increasing incidence of type 1 diabetes in 0-to 17-year-old Colorado youth. Diabetes Care 2007; 30:503-509
17. Hummel K, McFann KK, Realsen J, Messer LH, Klingensmith GJ, Chase HP. The increasing onset of type 1 diabetes in children. J Pediatr 2012;161:652-7.e1
18. Lipman TH, Levitt Katz LE, Ratcliffe SJ, et al. Increasing incidence of type 1 diabetesin youth: twenty years of the Philadelphia Pediatric Diabetes Registry. Diabetes Care 2013;36:1597-1603
19. Hannon TS, Rao G, Arslanian SA. Childhood obesity and type 2 diabetes mellitus. Pediatrics 2005;116:473-480
20. Imperatore G, Boyle JP, Thompson TJ, et al.; SEARCH for Diabetes in Youth Study Group. Projections of type 1 and type 2 diabetes burden in the U.S. population aged ,20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care 2012; 35:2515-2520
21. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014;311: 806-814
22. Dayal D, Samprathi M, Jayaraman D, Kohat D, Bhalla AK. Secular trends of body mass index in North Indian children with Type 1 diabetes do not support the Accelerator Hypothesis. Clin En-docrinol (Oxf). 5 September 2015 [Epub ahead of print]. DOI: 10.1111/cen.129411
23. Tran F, Stone M, Huang CY, et al. Population-based incidence of diabetes in Australian youth aged 10-18 yr: increase in type 1 diabetes but not type 2 diabetes. Pediatr Diabetes 2014; 15:585-590
24. Bogdanović R. Diabetic nephropathy in children and adolescents. Pediatr Nephrol 2008;23: 507-525
25. American Diabetes Association. Standards of medical care in diabetesd 2015. Diabetes Care 2015;38(Suppl. 1):S70-S76
26. Zeitler P, Fu J, Tandon N, et al.; International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2014. Type 2 diabetes in the child and adolescent. Pediatr Diabetes 2014;15 (Suppl. 20):26-46
27. Nordwall M, Bojestig M, Arnqvist HJ, Ludvigsson J; Linköping Diabetes Complications Study. Declining incidence of severe retinopa-thy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linköping Diabetes Complications Study. Di-abetologia 2004;47:1266-1272
28. Sellers EA, Blydt-Hansen TD, Dean HJ, Gibson IW, Birk PE, Ogborn M. Macroalbuminuria and renal pathology in First Nation youth with type 2 diabetes. Diabetes Care 2009;32:786-790
29. Schultz CJ, Konopelska-Bahu T, Dalton RN, et al.; Oxford Regional Prospective Study Group. Microalbuminuria prevalence varies with age, sex, and puberty inchildrenwith type 1 diabetes followed from diagnosis in a longitudinal study. Diabetes Care 1999;22:495-502
30. Gallego PH, Bulsara MK, Frazer F, Lafferty AR, Davis EA, Jones TW. Prevalence and risk factors for microalbuminuria in a population-based sample of children and adolescents with T1DM in Western Australia. Pediatr Diabetes 2006;7:165-172
31. Klingensmith GJ, Connor CG, Ruedy KJ, et al.; Pediatric Diabetes Consortium. Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium. Pediatr Diabetes. 8 May 2015 [Epub ahead of print]. DOI: 10.1111/pedi.12281
32. Pettitt DJ, Talton J, Dabelea D, et al.; SEARCH for Diabetes in Youth Study Group. Prevalence of diabetes in U.S. youth in 2009: the SEARCH for Diabetes in Youth study. Diabetes Care 2014;37:402-408
33. Son MK, Yoo HY, Kwak BO, et al. Regression and progression of microalbuminuria in adolescents with childhood onset diabetes mellitus. Ann Pediatr Endocrinol Metab 2015;20:13-20
34. U.S. RenalData System. USRDS 2012 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States [Internet], 2012. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Available from http://www.usrds.org/2012/view/v1-02.aspx. Accessed 10 September 2015
35. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(Suppl. 1):S1-S266